BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38411341)

  • 1. Novel 532-nm Q-switched Nd: YAG laser for the treatment of melasma and rejuvenation: a prospective, randomized controlled comparison with 1,064-nm Q-switched Nd: YAG laser.
    Wu W; Su Q; Zhang Y; Du Y; Hu Y; Wang F
    Int J Dermatol; 2024 Feb; ():. PubMed ID: 38411341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
    Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
    J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma.
    Hong JK; Shin SH; Park SJ; Seo SJ; Park KY
    J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Fluence Q-Switched Nd: YAG Laser Toning and Q-Switched Ruby Laser in the Treatment of Melasma:A Comparative Split-Face Ultrastructural Study.
    Omi T; Yamashita R; Kawana S; Sato S; Naito Z
    Laser Ther; 2012 Mar; 21(1):15-4. PubMed ID: 24610976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
    Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
    Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments.
    Wong Y; Lee SS; Goh CL
    Ann Dermatol; 2015 Dec; 27(6):751-5. PubMed ID: 26719647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
    Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
    Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Melasma with the Photoacoustic Twin Pulse Mode of Low-Fluence 1,064 nm Q-Switched Nd:YAG Laser.
    Kim JY; Choi M; Nam CH; Kim JS; Kim MH; Park BC; Hong SP
    Ann Dermatol; 2016 Jun; 28(3):290-6. PubMed ID: 27274626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
    Agamia N; Apalla Z; Salem W; Abdallah W
    J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.